Click here to view the United Healthcare (UHC) Medical Policy Updates » April 2024 United…
BCBS Horizon Medical Policy Updates – May 2019
Click here to view the Blue Cross Blue Shield Horizon Medical Policy Updates »
May 2019 Medical Policy Updates:
- Alkylating Agent(s) [Temozolomide intravenous (Temodar)]
- Ambulance and Medical Transport Services or Ancillary Ambulance Items and Supplies
- Atezolizumab (Tecentriq)
- Avelumab (Bavencio)
- Belimumab (Benlysta)
- Belinostat (Beleodaq)
- Blepharoplasty
- Botulinum Toxin
- Breast Pumps
- Brentuximab Vedotin (Adcetris)
- Canakinumab (Ilaris)
- Carfilzomib (Kyprolis)
- Cerliponase Alfa (Brineura)
- Certolizumab Pegol (Cimzia)
- Compression Stockings
- Continuous or Intermittent Monitoring of Glucose in the Interstitial Fluid
- Cosmetic Procedures
- Cutaneous Electrogastrography (EGG)
- Daratumumab (Darzalex)
- Dermatologic Applications of Photodynamic Therapy
- Diagnosis and Medical Management of Obstructive Sleep Apnea Syndrome
- Drug Testing in Pain Management and Substance Use Disorder Treatment Settings
- Dry Needling of Myofascial Trigger Points
- Dupilumab (Dupixent)
- Dynamic Splinting Devices
- Edaravone (Radicava)
- Epithelial Cell Cytology in Breast Cancer Risk Assessment and High-Risk Patient Management (Ductal Lavage and Suction Collection Systems)
- Erythropoietin Therapy Epoetin Alfa Darbepoetin Alfa Pegylated (PEG)-epoetin Beta and Epoetin Alfa-epbx
- Explantation of Breast Implants
- Fulvestrant (Faslodex)
- Gazyva (Obinutuzumab)
- Gender Reassignment Surgery
- Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist [Degarelix (Firmagon)]
- Gonadotropin-Releasing Hormone Analogs
- Hyperbaric Oxygen Therapy
- Imlygic (Talimogene Laherparepvec)
- Inotuzumab Ozogamicin (Besponsa)
- Insulin Infusion Pumps
- Intravenous Immunoglobulin (IVIG) Therapy
- Lemtrada (Alemtuzumab)
- Marqibo (Vincristine Sulfate Liposome Injection)
- Medical Beds
- Molecular Analysis for Targeted Therapy for Non-Small-Cell Lung Cancer
- Monoclonal Interleukin-5 Antagonists [mepolizumab (Nucala) reslizumab (Cinqair) and benralizumab (Fasenra)]
- Mozobil (Plerixafor Injection)
- Ocrelizumab (Ocrevus)
- Ofatumumab (Arzerra)
- Omacetaxine Mepesuccinate (Synribo)
- Omalizumab (Xolair)
- Oxaliplatin (Eloxatin)
- Pediatric Intensive Feeding Programs
- Pralatrexate (Folotyn)
- Romiplostim (Nplate)
- Sebelipase alfa (Kanuma)
- Sipuleucel-T (Provenge)
- Surgical Treatment of Snoring and Obstructive Sleep Apnea Syndrome
- Testosterone [Implantable Testosterone Pellets (Testopel Pellets) Testosterone Undecanoate (Aveed)] Testosterone Cypionate (Depo-Testosterone) or Testosterone Enanthate (Delatestryl)]
- Tildrakizumab (Ilumya)
- Tocilizumab (Actemra)
- Topotecan Hydrochloride (Hycamtin) Injection
- Transpupillary Thermotherapy for Treatment of Choroidal Neovascularization
- Tumor Markers Other Than Prostate Specific Antigen (PSA)
- Ustekinumab (Stelara)
- Voretigene neparvovec-rzyl (Luxturna)
- Whole-Body CT Screening
Click here to view the Blue Cross Blue Shield Horizon Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
